Literature DB >> 11786499

Pharmacological properties of nociceptin/orphanin FQ-induced stimulation and inhibition of cyclic AMP formation in distinct layers of rat olfactory bulb.

Maria C Olianas1, Pierluigi Onali.   

Abstract

1. We recently reported that nociceptin/orphanin FQ (N/OFQ) inhibited forskolin-stimulated adenylyl cyclase activity and increased basal enzyme activity in membranes of the external plexiform layer (EPL) and granule cell layer (GRL), respectively, of the rat main olfactory bulb. In the present study we have characterized the pharmacological profile of the inhibitory and stimulatory responses by examining the effects of various N/OFQ receptor agonists and antagonists. 2. N/OFQ(1 - 13)NH(2) fully mimicked the inhibitory and stimulatory effects of N/OFQ with EC(50) values of 0.9 and 6.5 nM, respectively. N/OFQ(1 - 7) was inactive at concentrations up to 1 microM, whereas Ac-RYYRIK-NH(2) and [Phe(1)Psi(CH(2)NH)Gly(2)]N/OFQ(1 - 13)-NH(2) behaved as partial agonists in eliciting both responses. 3. The nonpeptidyl N/OFQ receptor antagonist J-113397 competitively counteracted the inhibitory and stimulatory effects of N/OFQ with pA(2) values of 8.63 and 8.70, respectively. Similarly, the peptidyl antagonist [Nphe(1)]N/OFQ(1 - 13)NH(2) potently antagonized the two effects with pA(2) values of 8.03 and 8.45, respectively. None of the antagonists per se affected adenylyl cyclase activity. 4. These data show that in distinct layers of rat olfactory bulb both the inhibitory and stimulatory effects of N/OFQ on cyclic AMP formation display pharmacological properties consistent with the involvement of N/OFQ receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786499      PMCID: PMC1573131          DOI: 10.1038/sj.bjp.0704477

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397).

Authors:  H Kawamoto; S Ozaki; Y Itoh; M Miyaji; S Arai; H Nakashima; T Kato; H Ohta; Y Iwasawa
Journal:  J Med Chem       Date:  1999-12-16       Impact factor: 7.446

2.  A potent and highly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist: J-113397.

Authors:  S Ozaki; H Kawamoto; Y Itoh; M Miyaji; Y Iwasawa; H Ohta
Journal:  Eur J Pharmacol       Date:  2000-01-17       Impact factor: 4.432

3.  Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord.

Authors:  M Inoue; I Shimohira; A Yoshida; A Zimmer; H Takeshima; T Sakurada; H Ueda
Journal:  J Pharmacol Exp Ther       Date:  1999-10       Impact factor: 4.030

4.  [Phe1phi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells.

Authors:  M C Olianas; C Maullu; A Ingianni; P Onali
Journal:  Neuroreport       Date:  1999-04-06       Impact factor: 1.837

5.  Effect of intrathecal nocistatin on the formalin-induced pain in mice versus that of nociceptin/orphanin FQ.

Authors:  H Nakano; T Minami; K Abe; T Arai; M Tokumura; N Ibii; E Okuda-Ashitaka; H Mori; S Ito
Journal:  J Pharmacol Exp Ther       Date:  2000-01       Impact factor: 4.030

6.  Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies.

Authors:  R Bigoni; S Giuliani; G Calo'; A Rizzi; R Guerrini; S Salvadori; D Regoli; C A Maggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1999-03       Impact factor: 3.000

7.  Rat central ORL-1 receptor uncouples from adenylyl cyclase during membrane preparation.

Authors:  H Okawa; R A Hirst; D Smart; A T McKnight; D G Lambert
Journal:  Neurosci Lett       Date:  1998-04-17       Impact factor: 3.046

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

Review 9.  Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more.

Authors:  T Darland; M M Heinricher; D K Grandy
Journal:  Trends Neurosci       Date:  1998-05       Impact factor: 13.837

10.  [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL1) receptor.

Authors:  J L Butour; C Moisand; C Mollereau; J C Meunier
Journal:  Eur J Pharmacol       Date:  1998-05-15       Impact factor: 4.432

View more
  1 in total

1.  Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.

Authors:  K Flau; A Redmer; S Liedtke; M Kathmann; E Schlicker
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.